ᱟᱨᱴᱤᱰᱤᱯᱤᱮ (ᱰᱤᱵᱤᱰᱤ) ᱯᱤᱰᱤᱰᱤᱥᱤᱰᱤ ᱖ᱰᱤᱵᱤ ᱰᱤᱟᱨᱵᱤᱰᱤᱟᱨᱟᱨ ᱨᱮᱰᱰᱤᱵᱷᱤᱴᱤ ᱾

ᱥᱮᱨᱮᱧ ᱧᱩᱛᱩᱢ:
ᱮᱱ--, (᱒) − } ^ᱡᱤ-᱑ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱾
ᱠᱚᱥᱢᱮᱡᱤᱝ ᱠᱟᱨᱰᱤᱭᱚᱜᱽᱨ: ᱑᱒᱕-᱑᱒᱘᱾
ᱠᱚᱥᱢᱮᱴᱤᱠᱥ: ᱖᱘-᱑᱒᱔᱾
{}}: } } }
ᱠᱚᱰ {|}: '}} } } }᱾
ᱯᱤᱯᱤᱯᱤ: ᱕/᱒ ᱠᱮᱡᱤ
ᱡᱤᱭᱚᱱ ᱨᱮᱭᱟᱜ ᱡᱤᱭᱚᱱ: ᱑᱒

ᱤᱱᱴᱮᱜᱽᱨᱮᱥᱚᱱ

ᱥᱚᱨᱥ:

ᱮᱱᱴᱤ ᱚᱠᱥᱤᱰᱮᱱᱴᱠᱚᱢᱮᱰᱤᱭᱟᱱ ᱧᱩᱛᱩᱢ	ᱮᱱ--, (᱒) − } ^ᱡᱤ-᱑ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱱᱳᱭᱟ ᱾
ᱠᱮᱢᱤᱠᱮᱞ ᱢᱮᱴᱟᱵᱚᱞᱤᱡᱽ	C₁₈H₂₄N₂
ᱢᱟᱭᱠᱨᱚᱣᱮᱵᱷᱤᱝ ᱥᱯᱤᱰ
ᱵᱮᱥ ᱪᱚᱨᱚᱠ ᱛᱮ	268.41
ᱜᱡᱚᱴᱱᱟ	0.986-1.00
ᱠᱚᱰ {}}} ᱰᱤᱯᱷᱚᱞᱴ	793-24-8
ᱯᱮᱠᱮᱡᱤᱝ	᱕/᱒ ᱢᱤᱢᱤᱴᱚᱨ
ᱡᱤᱭᱚᱱ ᱞᱟᱹᱜᱤᱫ	᱑᱒ ᱪᱟᱸᱫᱚ

ᱱᱟᱹᱢᱩᱱᱟ:

ᱥᱟᱨᱦᱟᱣ	ᱜᱡᱚᱴᱱᱟ
ᱥᱟᱨᱦᱟᱣ	ᱰᱤᱭᱟᱡᱽ
ᱢᱤᱫ ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱜᱚᱱᱚᱝ ᱟᱨ ᱵᱟᱝ ᱥᱚᱢᱟᱱ ᱰᱤᱜᱽᱨᱤ ᱠᱷᱚᱱ	44.0
ᱥᱤ ᱟᱨ ᱮᱥ ᱠᱷᱚᱱ ᱠᱚᱢ ᱥᱮ ᱕	0.30
ᱵᱟᱹᱲᱛᱤ ᱥᱮ ᱠᱚᱢ ᱥᱮ €᱑ ᱠᱷᱚᱱ ᱵᱟᱧᱪᱟᱣ ᱢᱮ	0.50

ᱮᱱᱴᱤᱵᱟᱭᱳᱴᱤᱠᱥ ᱨᱮᱭᱟᱜ ᱠᱟᱹᱢᱤᱦᱚᱨᱟ ᱨᱮ ᱔᱒᱐ ᱮᱱᱯᱤᱥᱤᱡᱤᱥᱤ ᱨᱩᱜᱤ ᱠᱚ ᱾

At present, the domestic mainstream anti-aging agent 4020 production process uses p-aminodiphenylamine and methyl isobutyl ketone as raw materials. Under the pressure of 5-16 MPa, the copper-based catalyst is used for hydrogenation reaction, and the anti-aging agent 4020 is obtained through the post-treatment process. . Although this process is continuous, easy to operate, ᱱᱚᱶᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱢᱮᱱᱠᱷᱟᱱ ᱱᱚᱶᱟ ᱠᱷᱚᱱ ᱵᱟᱰᱟᱭᱚᱜ ᱠᱟᱱᱟ ᱡᱮ 2004 ᱠᱷᱚᱱ 10% ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱵᱟᱹᱲᱛᱤ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱟᱨ ᱚᱱᱟ ᱠᱷᱚᱱ ᱵᱟᱹᱲᱛᱤ ᱫᱚ ᱵᱟᱝ ᱛᱟᱦᱮᱱᱟ, ᱟᱨ ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱟᱨ ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱟᱨ ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ᱾ ᱟᱹᱰᱤ ᱜᱟᱱ 2015-455, 2015, 2016 ᱨᱮ, ᱟᱹᱰᱤ ᱜᱟᱱ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱵᱮᱥ ᱠᱟᱹᱢᱤ ᱠᱟᱱᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱵᱮᱥ ᱜᱮᱭᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱵᱮᱥ ᱜᱮᱭᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ, ᱚᱱᱟ ᱫᱚ ᱟᱹᱰᱤ ᱵᱮᱥ ᱜᱮᱭᱟ᱾ 20039300000000005, Feboption 2005, rpm, https://shircution, rpm, https://shircution, rpm, https://shaptions, rpm, ᱟᱨ rpm (tegration 22) ᱠᱷᱚᱱ ᱰᱟᱴᱟ ᱫᱚ ᱵᱟᱝ ᱧᱟᱢ ᱟᱠᱟᱱᱟ, ᱚᱱᱟ ᱫᱚ ᱰᱟᱴᱟ ᱵᱟᱝ ᱧᱟᱢ ᱟᱠᱟᱱᱟ, ᱚᱱᱟ ᱫᱚ ᱵᱟᱝ ᱧᱟᱢ ᱟᱠᱟᱱᱟ᱾ 0.353: 0.003() { } , ixx impoxt ᱰᱤᱡᱟᱭᱤᱱᱟᱨ ᱠᱚ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫ ᱠᱟᱹᱢᱤᱦᱚᱨᱟ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ, ᱟᱨ ᱚᱱᱟ ᱨᱮᱭᱟᱜ ᱢᱤᱫ ᱦᱟᱹᱴᱤᱧ ᱫᱚ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ, ᱟᱨ ᱥᱟᱶᱛᱮ ᱥᱚᱡᱷᱮ ᱠᱟᱹᱢᱤ ᱦᱚᱨᱟ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫ ᱴᱷᱟᱶ ᱵᱮᱱᱟᱣ᱾

ᱦᱚᱜᱽᱥ: ᱤᱞᱮᱠᱴᱨᱳᱰ, ᱮᱱᱴᱤᱵᱚᱰᱤᱡᱽ, ᱮᱱᱴᱤᱵᱟᱭᱚᱴᱤᱠ, ᱜᱞᱩᱠᱚᱡᱽ, ᱜᱞᱩᱠᱚᱡᱽ, ᱜᱞᱩᱠᱚᱡᱽ, ᱜᱞᱩᱠᱚᱡᱽ, ᱜᱞᱩᱠᱚᱡᱽ, ᱟᱨᱟᱵᱤᱰ, ᱟᱨᱟᱵᱤᱰ, ᱟᱨᱟᱵᱤᱰ, ᱟᱨᱟᱵᱤᱰᱭ (ᱮᱠᱮᱱ), ᱟᱨᱟᱵᱤᱰᱟᱹᱣ, ᱟᱨᱟᱵᱤᱰᱟᱹᱣ